Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro

Hepatic inflammation and injury may result from the translocation of pathological bacteria and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to inflammation by exhibiting immunoregulatory effects. Therefore, this study was conducted to evaluate lipid reduction and im...

Full description

Saved in:
Bibliographic Details
Main Authors: Paulraj Kanmani, AbuZar Ansari, Julio Villena, Hojun Kim
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/3876896
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548680865939456
author Paulraj Kanmani
AbuZar Ansari
Julio Villena
Hojun Kim
author_facet Paulraj Kanmani
AbuZar Ansari
Julio Villena
Hojun Kim
author_sort Paulraj Kanmani
collection DOAJ
description Hepatic inflammation and injury may result from the translocation of pathological bacteria and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to inflammation by exhibiting immunoregulatory effects. Therefore, this study was conducted to evaluate lipid reduction and immunoregulatory potentials of probiotic bacteria in vitro. HepG2 cells treated with total cellular fluid (TCF) of LABs reduced lipid accumulation. Moreover, cells responded to lipopolysaccharide (LPS) by producing higher levels of IL-6, IL-8, MCP-1, and TNF-α. TCF of LABs treatment showed remarkably diminished levels of the expression of these cytokines via modulation of the expression of TLR-negative regulators, as well as MAPK and NF-κB pathways. Moreover, heat-killed LABs were able to diminish TGF-β, IL-1β, and IL-6 and to increase IL-10 and TLR4 levels in THP-1 cells. LABs also decreased the protein level of TNF-α. These results demonstrated that immunobiotics exhibit potent immunoregulatory activity and may be used as effective therapeutic agents to alleviate inflammatory response.
format Article
id doaj-art-771f09abb87b40e7b22165e07c5da2a7
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-771f09abb87b40e7b22165e07c5da2a72025-02-03T06:13:18ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/38768963876896Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In VitroPaulraj Kanmani0AbuZar Ansari1Julio Villena2Hojun Kim3Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang, Republic of KoreaDepartment of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang, Republic of KoreaLaboratory of Immunobiotechnology, Reference Centre for Lactobacilli (CERELA-CONICET), Tucuman, ArgentinaDepartment of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang, Republic of KoreaHepatic inflammation and injury may result from the translocation of pathological bacteria and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to inflammation by exhibiting immunoregulatory effects. Therefore, this study was conducted to evaluate lipid reduction and immunoregulatory potentials of probiotic bacteria in vitro. HepG2 cells treated with total cellular fluid (TCF) of LABs reduced lipid accumulation. Moreover, cells responded to lipopolysaccharide (LPS) by producing higher levels of IL-6, IL-8, MCP-1, and TNF-α. TCF of LABs treatment showed remarkably diminished levels of the expression of these cytokines via modulation of the expression of TLR-negative regulators, as well as MAPK and NF-κB pathways. Moreover, heat-killed LABs were able to diminish TGF-β, IL-1β, and IL-6 and to increase IL-10 and TLR4 levels in THP-1 cells. LABs also decreased the protein level of TNF-α. These results demonstrated that immunobiotics exhibit potent immunoregulatory activity and may be used as effective therapeutic agents to alleviate inflammatory response.http://dx.doi.org/10.1155/2019/3876896
spellingShingle Paulraj Kanmani
AbuZar Ansari
Julio Villena
Hojun Kim
Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
Journal of Immunology Research
title Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
title_full Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
title_fullStr Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
title_full_unstemmed Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
title_short Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro
title_sort immunobiotics beneficially modulate tlr4 signaling triggered by lipopolysaccharide and reduce hepatic steatosis in vitro
url http://dx.doi.org/10.1155/2019/3876896
work_keys_str_mv AT paulrajkanmani immunobioticsbeneficiallymodulatetlr4signalingtriggeredbylipopolysaccharideandreducehepaticsteatosisinvitro
AT abuzaransari immunobioticsbeneficiallymodulatetlr4signalingtriggeredbylipopolysaccharideandreducehepaticsteatosisinvitro
AT juliovillena immunobioticsbeneficiallymodulatetlr4signalingtriggeredbylipopolysaccharideandreducehepaticsteatosisinvitro
AT hojunkim immunobioticsbeneficiallymodulatetlr4signalingtriggeredbylipopolysaccharideandreducehepaticsteatosisinvitro